90 related articles for article (PubMed ID: 27840983)
1. The transcription factor RFX5 is a transcriptional activator of the TPP1 gene in hepatocellular carcinoma.
Zhao Y; Xie X; Liao W; Zhang H; Cao H; Fei R; Wang X; Wei L; Shao Q; Chen H
Oncol Rep; 2017 Jan; 37(1):289-296. PubMed ID: 27840983
[TBL] [Abstract][Full Text] [Related]
2. RFX5 promotes the progression of hepatocellular carcinoma through transcriptional activation of KDM4A.
Chen DB; Xie XW; Zhao YJ; Wang XY; Liao WJ; Chen P; Deng KJ; Fei R; Qin WY; Wang JH; Wu X; Shao QX; Wei L; Chen HS
Sci Rep; 2020 Sep; 10(1):14538. PubMed ID: 32883983
[TBL] [Abstract][Full Text] [Related]
3. Regulatory factor X5 promotes hepatocellular carcinoma progression by transactivating tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta and suppressing apoptosis.
Chen DB; Zhao YJ; Wang XY; Liao WJ; Chen P; Deng KJ; Cong X; Fei R; Wu X; Shao QX; Wei L; Xie XW; Chen HS
Chin Med J (Engl); 2019 Jul; 132(13):1572-1581. PubMed ID: 31188160
[TBL] [Abstract][Full Text] [Related]
4. Tripeptidyl peptidase I promotes human endometrial epithelial cell adhesive capacity implying a role in receptivity.
Santos LL; Ling CK; Dimitriadis E
Reprod Biol Endocrinol; 2020 Dec; 18(1):124. PubMed ID: 33317560
[TBL] [Abstract][Full Text] [Related]
5. Partial genetic suppression of a loss-of-function mutant of the neuronal ceroid lipofuscinosis-associated protease TPP1 in Dictyostelium discoideum.
Phillips JE; Gomer RH
Dis Model Mech; 2015 Feb; 8(2):147-56. PubMed ID: 25540127
[TBL] [Abstract][Full Text] [Related]
6. Clinical study in Chinese patients with late-infantile form neuronal ceroid lipofuscinoses.
Chang X; Huang Y; Meng H; Jiang Y; Wu Y; Xiong H; Wang S; Qin J
Brain Dev; 2012 Oct; 34(9):739-45. PubMed ID: 22245569
[TBL] [Abstract][Full Text] [Related]
7. Global Brain Transcriptome Analysis of a Tpp1 Neuronal Ceroid Lipofuscinoses Mouse Model.
Domowicz MS; Chan WC; Claudio-Vázquez P; Henry JG; Ware CB; Andrade J; Dawson G; Schwartz NB
ASN Neuro; 2019; 11():1759091419843393. PubMed ID: 31003587
[TBL] [Abstract][Full Text] [Related]
8. A tripeptidyl peptidase 1 is a binding partner of the Golgi pH regulator (GPHR) in
Stumpf M; Müller R; Gaßen B; Wehrstedt R; Fey P; Karow MA; Eichinger L; Glöckner G; Noegel AA
Dis Model Mech; 2017 Jul; 10(7):897-907. PubMed ID: 28546289
[TBL] [Abstract][Full Text] [Related]
9. Two Separation-of-Function Isoforms of Human TPP1 Dictate Telomerase Regulation in Somatic and Germ Cells.
Grill S; Bisht K; Tesmer VM; Shami AN; Hammoud SS; Nandakumar J
Cell Rep; 2019 Jun; 27(12):3511-3521.e7. PubMed ID: 31216472
[TBL] [Abstract][Full Text] [Related]
10. FOXM1 promotes proliferation in human hepatocellular carcinoma cells by transcriptional activation of CCNB1.
Chai N; Xie HH; Yin JP; Sa KD; Guo Y; Wang M; Liu J; Zhang XF; Zhang X; Yin H; Nie YZ; Wu KC; Yang AG; Zhang R
Biochem Biophys Res Commun; 2018 Jun; 500(4):924-929. PubMed ID: 29705704
[TBL] [Abstract][Full Text] [Related]
11. Lysosomal enzyme tripeptidyl peptidase 1 destabilizes fibrillar Aβ by multiple endoproteolytic cleavages within the β-sheet domain.
Solé-Domènech S; Rojas AV; Maisuradze GG; Scheraga HA; Lobel P; Maxfield FR
Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1493-1498. PubMed ID: 29378960
[TBL] [Abstract][Full Text] [Related]
12. Elevated levels of tripeptidyl peptidase 1 do not ameliorate pathogenesis in a mouse model of Alzheimer disease.
Sleat DE; Maita I; Banach-Petrosky W; Larrimore KE; Liu T; Cruz D; Baker L; Maxfield FR; Samuels B; Lobel P
Neurobiol Aging; 2022 Oct; 118():106-107. PubMed ID: 35914472
[TBL] [Abstract][Full Text] [Related]
13. Functional consequences and rescue potential of pathogenic missense mutations in tripeptidyl peptidase I.
Walus M; Kida E; Golabek AA
Hum Mutat; 2010 Jun; 31(6):710-21. PubMed ID: 20340139
[TBL] [Abstract][Full Text] [Related]
14. Autosomal recessive spinocerebellar ataxia 7 (SCAR7) is caused by variants in TPP1, the gene involved in classic late-infantile neuronal ceroid lipofuscinosis 2 disease (CLN2 disease).
Sun Y; Almomani R; Breedveld GJ; Santen GW; Aten E; Lefeber DJ; Hoff JI; Brusse E; Verheijen FW; Verdijk RM; Kriek M; Oostra B; Breuning MH; Losekoot M; den Dunnen JT; van de Warrenburg BP; Maat-Kievit AJ
Hum Mutat; 2013 May; 34(5):706-13. PubMed ID: 23418007
[TBL] [Abstract][Full Text] [Related]
15. AAV gene transfer delays disease onset in a TPP1-deficient canine model of the late infantile form of Batten disease.
Katz ML; Tecedor L; Chen Y; Williamson BG; Lysenko E; Wininger FA; Young WM; Johnson GC; Whiting RE; Coates JR; Davidson BL
Sci Transl Med; 2015 Nov; 7(313):313ra180. PubMed ID: 26560358
[TBL] [Abstract][Full Text] [Related]
16. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
Li Z; Zhang H; Yang J; Hao T; Li S
Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
[TBL] [Abstract][Full Text] [Related]
17. Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma.
Kuo CC; Shih YL; Su HY; Yan MD; Hsieh CB; Liu CY; Huang WT; Yu MH; Lin YW
World J Gastroenterol; 2015 Apr; 21(13):3960-9. PubMed ID: 25852282
[TBL] [Abstract][Full Text] [Related]
18. Multifocal retinopathy in Dachshunds with CLN2 neuronal ceroid lipofuscinosis.
Whiting RE; Pearce JW; Castaner LJ; Jensen CA; Katz RJ; Gilliam DH; Katz ML
Exp Eye Res; 2015 May; 134():123-32. PubMed ID: 25697710
[TBL] [Abstract][Full Text] [Related]
19. A High-Content Screen Identifies TPP1 and Aurora B as Regulators of Axonal Mitochondrial Transport.
Shlevkov E; Basu H; Bray MA; Sun Z; Wei W; Apaydin K; Karhohs K; Chen PF; Smith JLM; Wiskow O; Roet K; Huang X; Eggan K; Carpenter AE; Kleiman RJ; Schwarz TL
Cell Rep; 2019 Sep; 28(12):3224-3237.e5. PubMed ID: 31533043
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the RFX complex and the RFX5(L66A) mutant: implications for the regulation of MHC class II gene expression.
Garvie CW; Stagno JR; Reid S; Singh A; Harrington E; Boss JM
Biochemistry; 2007 Feb; 46(6):1597-611. PubMed ID: 17279624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]